Pacylex

Pacylex Pharmaceuticals Presents New Data on the Mechanism of Action of Myristoylation Inhibition

A myristoylation inhibition gene expression signature, MISS-91 (Myristoylation Inhibitors Sensitivity Signature), will be presented at the European Association for Cancer Research (EACR) 2023 Congress.

Read More

Recent News

Pacylex

Pacylex Pharmaceuticals Presents New Data on the Mechanism of Action of Myristoylation Inhibition

Read More

Pacylex

Pacylex Pharmaceuticals Announces First Patient Dosed in a Phase 2a Study of PCLX-001 in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

Read More

Pacylex

Pacylex Pharmaceuticals Reports a Potential Drug Sensitivity Gene Signature and the Effects of Myristoylation Inhibition on Angiogenesis and Cancer Cell Migration at American Association of Cancer Research (AACR) 2023.

Read More
Follow Pacylex